CN110831931A - Thioether derivatives of dibenzothiophenes and dibenzofurans - Google Patents

Thioether derivatives of dibenzothiophenes and dibenzofurans Download PDF

Info

Publication number
CN110831931A
CN110831931A CN201880043929.9A CN201880043929A CN110831931A CN 110831931 A CN110831931 A CN 110831931A CN 201880043929 A CN201880043929 A CN 201880043929A CN 110831931 A CN110831931 A CN 110831931A
Authority
CN
China
Prior art keywords
formula
independently
atoms
group
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201880043929.9A
Other languages
Chinese (zh)
Other versions
CN110831931B (en
Inventor
L·列特扎
A·戈茨
H·赫施曼
M·恩格尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of CN110831931A publication Critical patent/CN110831931A/en
Application granted granted Critical
Publication of CN110831931B publication Critical patent/CN110831931B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76Dibenzothiophenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3491Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • C09K2019/3408Five-membered ring with oxygen(s) in fused, bridged or spiro ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to 4, 6-dihalodibenzothiophene and 4, 6-dihalodibenzofuran-3-thioether derivatives of formula (I), wherein W, X, R1、R2、A1、Z1And m is as defined in claim 1, to their preparation, to their use as a component in liquid-crystalline media, and to electro-optical display elements containing the liquid-crystalline media according to the invention.

Description

Thioether derivatives of dibenzothiophenes and dibenzofurans
Technical Field
The present invention relates to 4, 6-dihalodibenzothiophene and 4, 6-dihalodibenzofuran-3-thioether derivatives, to processes for their preparation, to liquid-crystalline media comprising these derivatives, and to electro-optical display elements containing these liquid-crystalline media. The compound has negative dielectric anisotropy.
Background
Since the discovery of the first commercially available liquid crystal compounds about 30 years ago, liquid crystals have found a wide range of applications. Known fields of application of conventional mixtures are, in particular, displays for watches and pocket calculators, and large display panels as used in railway stations, airports and sports grounds. Further fields of application are displays for portable and desktop computers, navigation systems and video applications. Especially for the last-mentioned applications, high demands are made on the response time and the contrast of the image.
The spatially ordered arrangement of molecules in a liquid crystal results in many of its properties being direction dependent. Here, anisotropy in particular with respect to optical, dielectric and elasto-mechanical properties is important for the use in liquid crystal displays. Depending on whether the molecules are oriented with their longitudinal axes perpendicular or parallel to the two plates of the capacitor, they have different capacitances; the dielectric constant epsilon of the liquid-crystalline medium is thus of different magnitude for both orientations. Substances with a higher dielectric constant in the case of a perpendicular orientation of the longitudinal axis of the molecules with respect to the capacitor plates are said to be dielectrically positive compared to the case of a parallel arrangement. In other words, the dielectric constant ε if parallel to the longitudinal axis of the molecule||Greater than the dielectric constant ε perpendicular to the longitudinal axis of the moleculeThen the dielectric anisotropy Deltaε||Greater than 0. Most liquid crystals used in conventional displays fall into this category.
Both the polarizability of the molecules and the permanent dipole moment contribute to the dielectric anisotropy. When a voltage is applied to the display, the longitudinal axes of the molecules self-align in the following manner: the larger of the dielectric constants becomes effective. The strength of the interaction with the electric field depends here on the difference between these two constants.
In the case of liquid crystal molecules used in conventional liquid crystal displays, the dipole moment oriented along the longitudinal axis of the molecules is larger than the dipole moment oriented perpendicular to the longitudinal axis of the molecules.
Very high performance displays have been developed using liquid crystals in which the larger dipole moment is oriented parallel to the longitudinal axis of the molecules. Here, in most cases, mixtures of 5 to 20 components are used in an effort to achieve a sufficiently wide temperature range of the mesophase as well as short response times and low threshold voltages. However, in the case of liquid crystal displays as used, for example, for notebook computers, the strong viewing angle dependence still causes difficulties. The best image quality is achieved if the surface of the display is perpendicular to the viewing direction of the viewer. If the display is skewed with respect to the viewing direction, the image quality is in some cases drastically degraded. For greater comfort, efforts are underway to maximize the angle at which the display can be skewed from the viewing direction of the viewer without significantly degrading image quality. Attempts have recently been made to improve the viewing angle dependence using liquid crystalline compounds having a dipole moment perpendicular to the longitudinal axis of the molecules larger than a dipole moment parallel to the longitudinal axis of the molecules. In this case, the dielectric anisotropy Δ ∈ is negative. In the absence of an electric field, the molecules are oriented with their longitudinal axes perpendicular to the glass surface of the display. The electric field is applied such that they orient themselves more or less parallel to the glass surface. In this way, an improvement in viewing angle dependence has been achieved. This type of display is known as a VA-TFT display (derived from the english "vertical alignment").
The development in the field of liquid crystal materials is still far from being completed. In order to improve the performance of liquid crystal display elements, efforts are constantly being made to develop new compounds that enable such displays to be optimized.
Publications EP 2937342, WO 02/055463, DE 102005012585 and EP 1752510 disclose dibenzothiophene derivatives as liquid crystal materials. The compounds differ from the compounds according to the invention by substitution of the dibenzothiophene structure. Publication EP 2921487 discloses dibenzofuran derivatives as liquid crystal materials. Thioethers in the 3-position of the ring system are not disclosed in the citations.
Disclosure of Invention
It is an object of the present invention to provide compounds having advantageous properties for use in liquid-crystalline media. In particular, they should have a negative dielectric anisotropy, which makes them particularly suitable for use in liquid-crystalline media for VA displays. The desired compounds have an advantageous combination of application-technical parameters, irrespective of the dielectric anisotropy corresponding to the display type. Among these parameters to be simultaneously optimized, mention may be made in particular of high bright spots, low rotational viscosity, optical anisotropy in the range of applications and the properties for obtaining mixtures having the desired liquid-crystalline phase in a wide temperature range (low melting point, good miscibility with other liquid-crystalline components of the desired kind).
This object is achieved according to the invention by compounds of the general formula I:
Figure BDA0002344671910000031
wherein
X independently represents F or Cl, preferably F,
w represents S or O, preferably S,
m represents 0, 1 or 2, preferably 0,
R1and R2Independently of one another, alkyl or alkoxy having 1 to 15C atoms, where one or more CH groups are present in these radicals2The radicals may also be substituted in each case independently of one another by-C.ident.C-, -CF2O-、-OCF2-、-CH=CH-、
Figure BDA0002344671910000032
Figure BDA0002344671910000033
-O-, -S-, -CO-O-or-O-CO-being replaced in such a way that the O atoms are not directly linked to one another, and wherein one or more H atoms can also be replaced by halogen,
preferably independently of one another, unsubstituted alkyl or alkoxy having 1 to 15 carbon atoms or alkenyl, alkenyloxy or alkynyl having 2 to 15C atoms, which in each case are optionally mono-or polyhalogenated,
A1independently at each occurrence, represents a group selected from the group consisting of:
a)1, 4-phenylene in which one or two CH groups may also be replaced by N and in which one or more H atoms may also be replaced by a group L,
b) a group consisting of: trans-1, 4-cyclohexylene and 1, 4-cyclohexenylene radicals in which one or more non-adjacent CH groups2The radicals may also be replaced by-O-and/or-S-, and where one or more H atoms may also be replaced by F or Cl, and
c) a group consisting of: tetrahydropyran-2, 5-diyl, 1, 3-diyl
Figure BDA0002344671910000041
Alk-2, 5-diyl, tetrahydrofuran-2, 5-diyl, cyclobutane-1, 3-diyl, piperidine-1, 4-diyl, thiophene-2, 5-diyl and selenophene-2, 5-diyl, which may also be mono-or polysubstituted by radicals L,
l represents independently for each occurrence F, Cl, CN, SCN, SF5Or straight-chain or branched, in each case optionally fluorinated, alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 12 or preferably 1 to 4C atoms, and
Z1independently of one another, represents a single bond, -CF2O-、-OCF2-、-CH2O-、-OCH2-、-(CO)O-、-O(CO)-、-(CH2)4-、-CH2CH2-、-CF2-CF2-、-CF2-CH2-、-CH2-CF2-、-CH=CH-、-CF=CF-、-CF=CH-、-CH=CF-、-(CH2)3O-、-O(CH2)3-、-C≡C-、-O-、-CH2-、-(CH2)3-or-CF2-。
Said compounds have a significantly negative Δ ∈ and are therefore particularly suitable for use in liquid-crystal mixtures for VA-TFT displays. Preferably, the compounds according to the invention have a.DELTA.epsilon.ltoreq.4, more preferably.DELTA.epsilon.ltoreq.7 and particularly preferably.DELTA.epsilon.ltoreq.9. They exhibit good miscibility with the customary substances used in liquid-crystal mixtures for displays, i.e. they have good solubility in them. The rotational viscosity of the compound and the resulting liquid crystal mixture is advantageously small without at the same time significantly reducing the clearing point of the mixture.
Other physical, physicochemical or electrooptical parameters of the compounds according to the invention are also advantageous for the use of the compounds in liquid-crystalline media. Liquid-crystalline media comprising these compounds have in particular a sufficient nematic phase width and good low-temperature and long-term stability and a sufficiently high clearing point. The low melting point of the compounds according to the invention indicates advantageous mixing properties. In addition, the compounds of the formula I according to the invention have, in particular, values of the optical anisotropy Δ n which are suitable for use in VA-TFT displays. Preferably, the compounds according to the invention have a Δ n of more than 0.15 and less than 0.25. In addition, the compounds are relatively easy to prepare. The balanced combination of these advantageous properties represents a significant enrichment of the mixed components that can be used in the VA mixture.
Determination of adjacent Ring System A1The parameter m of the number preferably has a value of 0 or 1, in particular 0.
R1In each case independently of one another preferably represents alkoxy, alkyl or alkenyl having 1 to 7 or 2 to 7 carbon atoms respectively. R in the general formula I1Particular preference is given to alkoxy or alkyl having 2 to 7C atoms.
R2Preferably represents an alkyl or alkenyl group having 1 to 7 or 2 to 7 carbon atoms, respectively. R in the general formula I2Particular preference is given to alkyl having 2 to 7C atoms.
For the case where m is 0, R1Preferably represents an alkoxy, alkyl or alkenyl group, particularly preferably an alkoxy group having 1 to 7C atoms, particularly preferably having 2 to 5C atoms. At R1And R2In general inThe sum of the number of carbon atoms of (a) is preferably 4, 5, 6, 7, 8, 9 or 10, particularly preferably 6, 7, 8, 9 or 10.
For m ═ 1 or 2, R1Preferably represents an alkyl, alkoxy or alkenyl group, particularly preferably an alkyl group having 1 to 7C atoms, particularly preferably having 2 to 7C atoms.
If R in formula I1And R2In each case independently of one another, represent alkyl, these are then straight-chain or branched. Preferably, each of these groups is straight-chain and, unless otherwise specified, has 1,2, 3, 4, 5, 6 or 7C atoms and is therefore preferably methyl, ethyl, propyl, butyl, pentyl, hexyl or heptyl.
If R in formula I1In each case independently of one another, represents an alkoxy group, which is then linear or branched. Preferably, each of these groups is straight-chain and, unless otherwise specified, has 1,2, 3, 4, 5, 6 or 7C atoms and is therefore preferably methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy or heptoxy.
R in formula I1And R2In each case independently of one another, may also be an alkenyl radical having 2 to 15C atoms which is unbranched or branched and has at least one C-C double bond. It is preferably unbranched and has 2 to 7C atoms. It is therefore preferably vinyl, prop-1-enyl or prop-2-enyl, but-1-, -2-or but-3-enyl, pent-1-, -2-, -3-or pent-4-enyl, hex-1-, -2-, -3-, -4-or hex-5-enyl or hept-1-, -2-, -3-, -4-, -5-or hept-6-enyl. If both C atoms of the C-C double bond are substituted, the alkenyl group may be present as E and/or Z-isomers (trans/cis). In general, the respective E-isomer is preferred. Among the alkenyl groups, prop-2-enyl, but-2-or but-3-enyl and pent-3-or pent-4-enyl are particularly preferred.
R in formula I1And R2Also independently of one another, alkynyl having 2 to 15C atoms, which are linear or branched and have at least one C-C triple bond. Preference is given to 1-or 2-propynyl and 1-, 2-or 3-butynyl.
One or more radicals A1Independently preferably represents a disubstituted cyclic group selected from the following formulae:
Figure BDA0002344671910000061
Figure BDA0002344671910000062
in particular
Figure BDA0002344671910000063
Figure BDA0002344671910000064
Group Z1Preferably represents a single bond, -CH2O-、-CF2O-or-OCF2-, particularly preferably a single bond.
The group L preferably represents F, Cl, -CF3Or an alkyl or alkoxy group having 1,2 or 3 carbon atoms.
Particularly preferably, m represents 0, and R1Represents an alkoxy group having 1 to 7 carbon atoms.
In connection with the present invention, halogen denotes fluorine, chlorine, bromine or iodine, preferably fluorine, chlorine or bromine, and especially fluorine or chlorine.
In connection with the present invention, the expression "alkyl", unless defined differently in the rest of the description or in the claims, denotes a straight-chain or branched, saturated, aliphatic hydrocarbon radical having from 1 to 15 (i.e. 1,2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15) carbon atoms.
The compounds of the formula I according to the invention are particularly preferably selected from the sub-formulae IA to IF:
wherein R is1、R2And A1Have the meanings as defined above for formula I, and
Z1is as defined above for formula IBut it is not a single bond.
Preferred compounds of formulae IA and ID are compounds of formulae IA-1 to IA-3 and ID-1 to ID-3,
wherein Alkyl and Alkyl*Independently of one another, straight-chain alkyl having 1 to 7C atoms, and Alkoxy, independently of one another, straight-chain Alkoxy having 1 to 7C atoms. Particular preference is given to compounds of the formula IA-1.
Preferred compounds of formulae IB and IC are compounds of the following formulae:
Figure BDA0002344671910000082
wherein Alkyl independently of one another denotes a straight-chain Alkyl radical having 1 to 7C atoms.
Particularly preferred compounds of formula I or IA-1 are selected from those of formulae IA-1-1 to IA-1-26:
Figure BDA0002344671910000092
Figure BDA0002344671910000101
Figure BDA0002344671910000111
if groups or substituents of the compounds according to the invention or the compounds according to the invention themselves are present as optically active or stereoisomeric groups, substituents or compounds, for example because they have asymmetric centers, these are encompassed by the invention. In this connection, it is self-evident that the compounds of the general formula I according to the invention can be present in isomerically pure form, for example as pure enantiomers, diastereomers, E or Z isomers, trans or cis isomers or as a mixture of a plurality of isomers in any desired ratio (for example as racemate), E/Z isomer mixtures or as cis/trans isomer mixtures.
Among the disclosed compounds for liquid crystal media, compounds of formulaThe 1, 4-substituted cyclohexyl ring of-or-Cyc-is preferably in the trans configuration, i.e., both substituents are at the equatorial position in the thermodynamically preferred chair conformation.
The compounds of the formula I can be synthesized by methods known per se, such as those described in the literature (for example in standard works, such as Houben-Weyl, Methoden der Organischen Chemie (methods of organic chemistry), Georg-Thieme-Verlag, Stuttgart), and more precisely under reaction conditions which are known and suitable for the reactions mentioned. In this connection, variants known per se which are not mentioned in more detail here can be used.
The starting materials may optionally also be formed in situ, so that they are not isolated from the reaction mixture but immediately reacted further to form the compounds of the general formula I.
The synthesis of the compounds of the general formula I according to the invention is described by way of example in the examples. The starting materials are either available through commonly available literature procedures or are commercially available.
A particularly suitable synthetic route for the compounds according to the invention is explained below with reference to the following scheme. Substituent R in the following scheme1、R2X, W and the index m have the meanings as given for formula I.
The synthesis of compounds of formula I, wherein W ═ S and m ═ 0, was carried out according to scheme 1, starting from the base compound.
Scheme 1. example Synthesis of dibenzothiophenes. R1=-OR,m=0。
The synthesis of the corresponding difluorodibenzofuran compounds (W ═ O, m ═ 0) is described, for example, in the publication US2015/0259602 a 1.
Figure BDA0002344671910000151
Scheme 2. two alternative synthetic routes to the compounds of formula I. Substituents are similarly defined.
The depicted reaction schemes are to be considered merely exemplary. Optionally, instead of the group-OR in scheme 1, it is also possible in general to combine the formula R1-[A1-Z1]mThe radical of-is similarly introduced into the formula I. Those skilled in the art may make corresponding changes to the proposed synthesis, as well as seek other suitable synthetic routes to obtain compounds of formula I.
In accordance with the syntheses set forth above, the present invention also includes, in one embodiment, one or more methods for preparing a compound of formula I.
The invention therefore comprises a process for the preparation of a compound of formula I, characterized in that it comprises a process step in which a compound of formula (B) is reacted at the OH group with trifluoromethanesulfonic acid or a reactive derivative thereof to form a compound of formula (C),
Figure BDA0002344671910000152
w, X, Z therein1、A1M and R1Independently as defined in formula I,
Figure BDA0002344671910000153
wherein independently of each other
OTf represents a group O (SO)2)CF3
And
W、X、Z1、A1m and R1Independently as defined in formula I, in particular as for formula (B);
and converting it in one or more further process steps to a compound of the formula I.
The esterification of the OH group of the compound of formula (B) with trifluoromethanesulfonic acid (derivative) is preferably carried out with trifluoromethanesulfonic chloride (TfCl) or trifluoromethanesulfonic anhydride (TfOTf).
The disclosed process steps and the subsequent work-up of the reaction mixture can in principle be carried out as a batch reaction or in continuous reaction mode. The continuous reaction mode includes, for example, reactions in continuous stirred tank reactors, stirred tank cascades, loop or cross-flow reactors, flow tubes or in microreactors. The work-up of the reaction mixture is optionally carried out by the following procedure, as required: filtration via a solid phase, chromatography, separation between immiscible phases (e.g., extraction), adsorption onto a solid support, distillation to remove solvent and/or azeotropic mixtures, selective distillation, sublimation, crystallization, co-crystallization, or nanofiltration through a membrane.
As already mentioned, the compounds of the formula I can be used in liquid-crystalline media. The present invention therefore also provides liquid-crystalline media comprising at least one compound of the general formula I having at least two liquid-crystalline compounds.
The present invention also provides liquid-crystalline media which, in addition to one or more compounds of the formula I according to the invention, comprise from 2 to 40, preferably from 4 to 30, components as further constituents. These media particularly preferably comprise, in addition to one or more compounds according to the invention, from 7 to 25 components. These further components are preferably selected from nematic or nematic (monotropic or isotropic) substances, in particular from the following classes: azoxybenzene, benzylidene aniline, biphenyl, terphenyl, 1, 3-bisAlkanes, 2, 5-tetrahydropyrans, phenyl or cyclohexyl benzoates, phenyl cyclohexanecarboxylates or ringsCyclohexyl hexanecarboxylate, phenyl cyclohexylbenzoate or cyclohexyl cyclohexylbenzoate, phenyl cyclohexylcyclohexanecarboxylate or cyclohexyl cyclohexylcyclohexanecarboxylate, cyclohexylphenyl benzoate, cyclohexylphenyl cyclohexanecarboxylate or cyclohexylphenyl cyclohexylcyclohexanecarboxylate, phenylcyclohexane, cyclohexylbiphenyl, phenylcyclohexylcyclohexane, cyclohexylcyclohexylcyclohexane, 1, 4-dicyclohexylbenzene, 4' -dicyclohexylbiphenyl, phenylpyrimidine or cyclohexylpyrimidine, phenylpyridine or cyclohexylpyridine, phenylbispyridine or cyclohexylpyridine, phenylbisphenyl
Figure BDA0002344671910000171
Alkane or cyclohexyl diAlkanes, phenyl-1, 3-dithianes or cyclohexyl-1, 3-dithianes, 1, 2-diphenylethane, 1, 2-dicyclohexylethane, 1-phenyl-2-cyclohexylethane, 1-cyclohexyl-2- (4-phenylcyclohexyl) ethane, 1-cyclohexyl-2-diphenylethane, 1-phenyl-2-cyclohexylphenylethane, optionally halogenated stilbenes, benzyl phenyl ethers, tolans and substituted cinnamic acids. The 1, 4-phenylene groups in these compounds may also be mono-or polyfluoro.
The most important compounds suitable as further constituents of the medium according to the invention can be characterized by the formulae (II), (III), (IV), (V) and (VI):
R'-L-E-R” (II)
R'-L-COO-E-R” (III)
R'-L-OOC-E-R” (IV)
R'-L-CH2CH2-E-R” (V)
R'-L-CF2O-E-R” (VI)
in the formulae (II), (III), (IV), (V) and (VI), L and E may be identical or different and in each case independently of one another represent a divalent radical selected from the group formed by the following structural elements: -Phe-, -Cyc-, -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -Pyr-, -Dio-, -Thp-, -G-Phe-and-G-Cyc-and their mirror images, wherein Phe represents unsubstituted or fluorine-substituted 1, 4-phenylene and Cyc representsTrans-1, 4-cyclohexylene or 1, 4-cyclohexenylene, Pyr represents pyrimidine-2, 5-diyl or pyridine-2, 5-diyl, Dio represents 1, 3-diyl
Figure BDA0002344671910000174
Alk-2, 5-diyl, Thp tetrahydropyran-2, 5-diyl and G2- (trans-1, 4-cyclohexyl) ethyl, pyrimidin-2, 5-diyl, pyridin-2, 5-diyl, 1, 3-diyl
Figure BDA0002344671910000175
Alkane-2, 5-diyl or tetrahydropyran-2, 5-diyl.
Preferably, one of the radicals L and E is Cyc or Phe. E is preferably Cyc, Phe or Phe-Cyc. The media according to the invention preferably comprise one or more components selected from the group consisting of the compounds of the formulae (II), (III), (IV), (V) and (VI) in which L and E are selected from Cyc and Phe, and at the same time also one or more components selected from the group consisting of the compounds of the formulae (II), (III), (IV), (V) and (VI) in which one of the radicals L and E is selected from Cyc and Phe and the other radical is selected from-Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -G-Phe-and-G-Cyc-, and optionally one or more components selected from the group consisting of the compounds of the formulae (II), (III), (IV), (V) and (VI) in which the radicals L and E are selected from-Phe-Cyc-, -Cyc-Cyc-, -G-Phe-and-G-Cyc-), (III), (IV), (V) and (VI).
In a smaller subgroup of the compounds of the formulae (II), (III), (IV), (V) and (VI), R 'and R' each, independently of one another, denote alkyl, alkenyl, alkoxy, alkoxyalkyl (oxaalkyl), alkenyloxy or alkanoyloxy having up to 8C atoms. This smaller sub-group is referred to hereinafter as group a, and the compounds are designated by sub-formulae (IIa), (IIIa), (IVa), (Va) and (VIa). In most of these compounds, R 'and R' are different from each other, wherein one of these groups is usually alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).
In a further smaller subgroup of the compounds of the formulae (II), (III), (IV), (V) and (VI), which is referred to as group B, E represents
Figure BDA0002344671910000181
In the compounds of group B, designated by sub-formulae (IIb), (IIIb), (IVb), (Vb) and (VIb), R' and R "have the meanings given in the case of the compounds of sub-formulae (IIa) to (VIa), and are preferably alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).
In another smaller sub-group of the compounds of formulae (II), (III), (IV), (V) and (VI), R' represents-CN. This subgroup is referred to below as group C, and the compounds of this subgroup are described by the sub-formulae (IIc), (IIIc), (IVc), (Vc) and (VIc), respectively. In the compounds of the sub-formulae (IIc), (IIIc), (IVc), (Vc) and (VIc), R' has the meaning given in the case of the compounds of the sub-formulae (IIa) to (VIa) and is preferably alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).
In addition to the preferred compounds of groups A, B and C, other compounds of formulae (II), (III), (IV), (V) and (VI) having different variations of the indicated substituents are also customary. All these substances can be obtained by methods known from the literature or analogously thereto.
In addition to the compounds of the formula I according to the invention, the media according to the invention preferably also comprise one or more compounds selected from the group A, B and/or C. The mass fractions of the compounds from these groups in the medium according to the invention are:
group A:
from 0 to 90%, preferably from 20 to 90%, in particular from 30 to 90%.
Group B:
from 0 to 80%, preferably from 10 to 80%, in particular from 10 to 70%.
Group C:
from 0 to 80%, preferably from 5 to 80%, in particular from 5 to 50%.
The media according to the invention preferably comprise from 1 to 40%, particularly preferably from 5 to 30%, of the compounds of the formula I according to the invention. The medium preferably comprises one, two, three, four or five compounds of the formula I according to the invention.
The preparation of the media according to the invention is carried out in a manner conventional per se. Generally, the components are dissolved in each other, preferably at elevated temperature. The liquid-crystalline phases of the invention can be modified by means of suitable additives in such a way that they can be used in all kinds of liquid-crystal display elements known hitherto. Additives of this type are known to the person skilled in the art and are described in detail in the literature (H.Kelker/R.Hatz, Handbook of Liquid Crystals, Verlag Chemie, Weinheim, 1980). For example, pleochroic dyes for preparing coloured guest-host systems or substances for modifying the dielectric anisotropy, the viscosity and/or the orientation of the nematic phase can be added.
Due to their negative Δ ε, the compounds of the formula I are particularly suitable for use in VA-TFT displays.
The invention therefore also provides electro-optical display elements containing the liquid-crystalline media according to the invention. The display element is preferably a VA-TFT display element (VA: vertical alignment; TFT: thin film transistor). In addition, there are other types of display elements that also use a medium having negative dielectric anisotropy.
Further embodiments of the invention result from the claims and the combination of two or more of these claims.
Detailed Description
The present invention is illustrated in more detail below with reference to examples, but the present invention is not intended to be limited by these examples. From the examples, those skilled in the art will be able to derive implementation details not given in the general description, to generalize them on the basis of the common general knowledge in the field, and to apply them to their specific problem cases.
In addition to the abbreviations that are commonly used and well known, the following abbreviations are used:
c: a crystalline phase; n: a nematic phase; sm: a smectic phase; i: an isotropic phase. The numbers between these symbols indicate the transition temperatures of the substances involved.
Unless otherwise indicated, temperature data are given in degrees celsius.
The physical, physicochemical or electrooptical parameters are determined according to generally known methods, such as, in particular, the booklet "Merck Liquid Crystals--Physical Properties of Liquid Crystals-Description of the Measurements Methods ", 1998, Merck KGaA, Darmstadt.
In the above and below, Δ n denotes the optical anisotropy (589nm, 20 ℃ C.) and Δ ε denotes the dielectric anisotropy (1kHz, 20 ℃ C.). The dielectric anisotropy. DELTA.. di-elect cons.was measured at 20 ℃ and 1 kHz. The optical anisotropy Δ n was measured at 20 ℃ and a wavelength of 589.3 nm.
Δ ε and Δ n values, extrapolated clearing point (cl.p.) and rotational viscosity (γ.) of the compounds according to the invention1) Obtained by linear extrapolation from a liquid-crystal mixture consisting of 5 to 10% of the corresponding compound according to the invention and 90 to 95% of a commercially available liquid-crystal mixture ZLI-2857 (for. DELTA.. epsilon., cl. p.) or ZLI-4792 (for. DELTA.n,. gamma.)1) Composition (mixture, from Merck KGaA, Darmstadt).
Hereinafter, abbreviations mean:
MTB methyl tert-butyl ether
THF tetrahydrofuran
DMAP 4- (dimethylamino) pyridine
m.p. melting Point
Examples
The starting materials are available according to commonly available literature procedures or are commercially available.
Example 1
Step 1
Figure BDA0002344671910000211
0.058mol of 2-bromo-6-fluorophenol is dissolved in 100ml of THF and mixed with 40ml of water and 0.09mol of potassium carbonate. After heating to boiling temperature, 0.3mmol of tris (dibenzylideneacetone) dipalladium (0) and 0.9mmol of palladium (0) were addedA (di (1-adamantyl) -n-butylphosphine) and 0.062mol (4-ethoxy-2) of the compound are added dropwise in the course of half an hour3-difluorophenyl) dimethoxyborane in 100ml of THF. The mixture is boiled under reflux for a further 16 hours, then mixed with water and MTB and worked up by extraction. The crude product, 4' -ethoxy-3, 2',3' -trifluorobiphenyl-2-ol, was purified by chromatography (eluent: chlorobutane). White crystals were obtained.
Step 2
Figure BDA0002344671910000213
0.022mol of 4' -ethoxy-3, 2',3' -trifluorobiphenyl-2-ol, 0.036mol of triethylamine and 0.6mmol of DMAP were dissolved in 50ml of dichloromethane. To this solution 0.03mol of trifluoromethanesulfonic anhydride are added dropwise at 5-10 ℃ over a half hour. Stir for an additional 1 hour without further cooling, and filter the batch with dichloromethane through a column containing silica gel. The filtrate was evaporated to give the triflate of 4' -ethoxy-3, 2',3' -trifluorobiphenyl-2-ol.
Step 3
Figure BDA0002344671910000221
0.022mol of the triflate of 4' -ethoxy-3, 2',3' -trifluorobiphenyl-2-ol and 0.024mol of ethyl mercaptopropionate were dissolved in 50ml of dry toluene and boiled with 2.2mmol of bis (2-diphenylphosphinophenyl) ether, 1.1mmol of tris- (dibenzylideneacetone) dipalladium (0) and 0.055mol of potassium carbonate under reflux for 24 hours. The reaction mixture is mixed with water and MTB and worked up by extraction. The organic phase was concentrated and the product was isolated by column chromatography over silica gel with 1-chlorobutane to give 0.014mol of ethyl 3- (4' -ethoxy-3, 2',3' -trifluorobiphenyl-2-ylsulfanyl) propionate.
Step 4
0.014mol of ethyl 3- (4' -ethoxy-3, 2',3' -trifluorobiphenyl-2-ylsulfanyl) -propionate was boiled with 0.017mol of potassium tert-butoxide in 50ml of THF under reflux for 14 h. The reaction mixture is mixed with water and MTB and worked up by extraction. The organic phase is concentrated and the product is isolated by column chromatography over silica gel using 1-chlorobutane. 3-ethoxy-4, 6-difluoro dibenzothiophene is obtained.
Step 5
Figure BDA0002344671910000231
0.013mol of 3-ethoxy-4, 6-difluorodibenzothiophene were dissolved in 50ml of THF and 11ml (0.017mol) of n-butyllithium (1.6M in hexane) were added dropwise at-70 ℃. The mixture was stirred at-70 ℃ for another 30 minutes, and then 0.017mol trimethyl borate (dissolved in a small amount of THF) was added at the same temperature. The reaction mixture was warmed to room temperature and then a mixture of 2ml acetic acid and 2.5ml water was added. 3ml of 30% hydrogen peroxide are then added dropwise at a temperature of up to 45 ℃. After a further 14 hours of subsequent stirring, the reaction mixture is mixed with water and MTB and worked up by extraction. The organic phase is concentrated and the product is isolated by column chromatography over silica gel with dichloromethane. 0.011mol of 7-ethoxy-4, 6-difluorodibenzothiophene-3-ol is obtained.
The following compounds were prepared analogously:
Figure BDA0002344671910000232
example 2
Figure BDA0002344671910000233
9.9g (30mmol) of phenol 1 (prepared analogously to example 1) are dissolved in 90ml of DCM and mixed with 8ml of triethylamine and 150mg of DMAP. 8ml (48mmol) of trifluoromethanesulfonic anhydride were added at 5 ℃. The batch was then stirred for 1 hour without cooling. The reaction solution was placed on silica gel and product 2 was eluted with DCM. Yield: 90 percent.
13.9g (30mmol) of trifluoromethanesulfonate 2 are reacted with 70ml of toluene and 4.5ml (73mmol) of ethane under protective gasMercaptan, 10.5g (76mmol) potassium carbonate, 1.6g (3.1mmol) bis (2-diphenylphosphinophenyl) ether and 1.4g (1.5mmol) tris (dibenzylideneacetone) dipalladium (0) were mixed and heated to boil overnight. Passing the cooled batch through
Figure BDA0002344671910000242
Filtered, concentrated and placed on silica gel. Product 3 was eluted with n-heptane.
Melting point: 73 deg.C.
Phase (1): C73N (26) I (see also table).
The following dibenzothiophene compounds were prepared in analogy to example 1:
Figure BDA0002344671910000241
unless otherwise stated, the radical R1/2Are straight-chain, i.e. unbranched. Material data can be found in table 1.
Table 1.
Figure BDA0002344671910000251
Trans) isomers
The following dibenzofuran compounds were prepared in analogy to example 1:
Figure BDA0002344671910000252
unless otherwise stated, the radical R1/2Are straight-chain, i.e. unbranched. Material data can be found in table 2.
Table 2.
Figure BDA0002344671910000261
Trans) isomers
Other compounds:
Figure BDA0002344671910000271

Claims (16)

1. a compound of formula I:
Figure FDA0002344671900000011
wherein
X independently represents F or Cl, preferably F,
w represents S or O, preferably S,
m represents 0, 1 or 2,
R1and R2Independently of one another, alkyl or alkoxy having 1 to 15C atoms, where one or more CH groups are present in these radicals2The radicals may also be substituted in each case independently of one another by-C.ident.C-, -CF2O-、-OCF2-、-CH=CH-、
Figure FDA0002344671900000013
-O-, -S-, -CO-O-or-O-CO-being replaced in such a way that the O atoms are not directly linked to one another, and wherein one or more H atoms can also be replaced by halogen,
A1independently at each occurrence, represents a group selected from the group consisting of:
a)1, 4-phenylene in which one or two CH groups may also be replaced by N and in which one or more H atoms may also be replaced by a group L,
b) a group consisting of: trans-1, 4-cyclohexylene and 1, 4-cyclohexenylene radicals in which one or more non-adjacent CH groups2The radicals may also be replaced by-O-and/or-S-, and where one or more H atoms may also be replaced by F or Cl, and
c) a group consisting of: tetrahydropyran-2, 5-diyl, 1, 3-diylAlkane-2, 5-diyl, tetrahydrofuran-2, 5-diylRadicals, cyclobutane-1, 3-diyl, piperidine-1, 4-diyl, thiophene-2, 5-diyl and selenophene-2, 5-diyl, which may also be mono-or polysubstituted by radicals L,
l represents independently for each occurrence F, Cl, CN, SCN, SF5Or straight-chain or branched, in each case optionally fluorinated, alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 12 or preferably 1 to 4C atoms, and
Z1independently of one another, represents a single bond, -CF2O-、-OCF2-、-CH2O-、-OCH2-、-(CO)O-、-O(CO)-、-(CH2)4-、-CH2CH2-、-CF2-CF2-、-CF2-CH2-、-CH2-CF2-、-CH=CH-、-CF=CF-、-CF=CH-、-CH=CF-、-(CH2)3O-、-O(CH2)3-、-C≡C-、-O-、-CH2-、-(CH2)3-or-CF2-。
2. A compound according to claim 1, characterized in that in formula I, m has the value 0.
3. A compound according to claim 1 or 2, characterized in that, in formula I,
R1represents unsubstituted alkyl or alkoxy having 1 to 15 carbon atoms or alkenyl, alkenyloxy or alkynyl having 2 to 15C atoms, which in each case are optionally mono-or polyhalogenated.
4. Compound according to one or more of claims 1 to 3, characterized in that, in formula I, R2Represents an alkyl or alkenyl group having 1 to 7 or 2 to 7 carbon atoms, respectively.
5. Compound according to one or more of claims 1 to 4, characterized in that, in formula I, W represents S.
6. The compound according to one or more of claims 1 to 4, characterized in that the compound of formula I is selected from the sub-formulae IA to IC and ID to IF:
Figure FDA0002344671900000021
Figure FDA0002344671900000031
wherein
R1、R2、A1And Z1Have the meaning as for formula I according to claim 1, wherein Z1No single bond is represented here.
7. The compound according to one or more of claims 1 to 6, characterized in that the compound is selected from the compounds of formulae IA-1 to IA-3 and ID-1 to ID-3,
Figure FDA0002344671900000032
Figure FDA0002344671900000041
wherein Alkyl and Alkyl*Independently of one another, straight-chain alkyl having 1 to 7C atoms, and Alkoxy, independently of one another, straight-chain Alkoxy having 1 to 7C atoms.
8. Compound according to one or more of claims 1 to 7, characterized in that X represents F.
9. Compound according to one or more of claims 1 to 8, characterized in that R1Represents an alkoxy group having 1 to 7 carbon atoms.
10. Compound according to one or more of claims 1 to 9, characterized in that
m is 1 or 2, and
ring A1Independently selected in each case from the structural moiety
Figure FDA0002344671900000051
11. Use of one or more compounds according to one or more of claims 1 to 10 in liquid-crystalline media.
12. Liquid-crystalline medium comprising at least two compounds, characterized in that it comprises at least one compound according to one or more of claims 1 to 10.
13. A liquid-crystalline medium according to claim 12, comprising at least one polymerizable compound.
14. Electro-optical display element containing a liquid-crystalline medium according to claim 12 or 13.
15. The electro-optic display element of claim 14 which uses polymer stabilized or polymer induced liquid crystal alignment.
16. A process for preparing compounds of the formula I according to one or more of claims 1 to 10, characterized in that the process comprises a process step in which a compound of the formula (B) is reacted at the OH group with trifluoromethanesulfonic acid or a reactive derivative thereof,
Figure FDA0002344671900000052
independently of one another, W, X, Z1、A1M and R1Is as defined in formula I according to any one of claims 1 to 9,
to form a compound of formula (C),
wherein independently of each other, the first and second substrates,
OTf represents a group O (SO)2)CF3
And
W、X、Z1、A1m and R1Independently as defined in formula I according to any one of claims 1 to 9;
and converting it in one or more further process steps to a compound of the formula I.
CN201880043929.9A 2017-07-03 2018-06-29 Thioether derivatives of dibenzothiophenes and dibenzofurans Active CN110831931B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102017006284.6A DE102017006284A1 (en) 2017-07-03 2017-07-03 Thioether derivatives of dibenzothiophene and dibenzofuran
DE102017006284.6 2017-07-03
PCT/EP2018/067528 WO2019007821A1 (en) 2017-07-03 2018-06-29 Thioether-derivatives of dibenzothiophens and dibenzofurans

Publications (2)

Publication Number Publication Date
CN110831931A true CN110831931A (en) 2020-02-21
CN110831931B CN110831931B (en) 2023-06-16

Family

ID=62837900

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880043929.9A Active CN110831931B (en) 2017-07-03 2018-06-29 Thioether derivatives of dibenzothiophenes and dibenzofurans

Country Status (4)

Country Link
CN (1) CN110831931B (en)
DE (2) DE102017006284A1 (en)
TW (1) TWI787298B (en)
WO (1) WO2019007821A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112195030A (en) * 2020-09-14 2021-01-08 北京八亿时空液晶科技股份有限公司 Liquid crystal composition containing tetrahydropyran and terphenyl and application thereof
WO2022218217A1 (en) * 2021-04-15 2022-10-20 江苏和成显示科技有限公司 Liquid crystal composition and liquid crystal display device thereof
WO2022228071A1 (en) * 2021-04-27 2022-11-03 江苏和成显示科技有限公司 Liquid crystal compound, liquid crystal composition thereof, and liquid crystal display device

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3628721B1 (en) 2018-09-27 2023-03-01 Merck Patent GmbH Liquid-crystal medium
EP3666853B1 (en) * 2018-12-10 2021-06-16 Merck Patent GmbH Liquid-crystal medium

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1912052A (en) * 2005-08-09 2007-02-14 默克专利股份有限公司 Liquid-crystalline medium
CN104926765A (en) * 2014-03-17 2015-09-23 默克专利股份有限公司 4,6-difluorodibenzofuran derivatives
CN105153112A (en) * 2014-04-22 2015-12-16 默克专利股份有限公司 4,6-difluoro dibenzothiophene derivates
CN106045953A (en) * 2015-04-13 2016-10-26 默克专利股份有限公司 Fluorinated dibenzofuran and dibenzothiophene derivative
WO2020055463A1 (en) * 2018-09-14 2020-03-19 Apple Inc. Magnetic layout in electronic devices and accessory devices for electronic devices

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10101022A1 (en) 2001-01-11 2002-07-18 Clariant Internat Ltd Muttenz Fluorinated aromatics and their use in liquid crystal mixtures
EP1742931B1 (en) 2004-04-14 2014-04-23 Merck Patent GmbH Dibenzofuran, dibenzothiophene and fluorene derivatives as components of liquid-crystalline mixtures
US8303844B2 (en) * 2007-11-27 2012-11-06 Merck Patent Gesellschaft Mit Beschrankter Haftung Benzo[f]chrome any pyrano[3,2-f]chrome derivatives for use in liquid crystal media

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1912052A (en) * 2005-08-09 2007-02-14 默克专利股份有限公司 Liquid-crystalline medium
CN104926765A (en) * 2014-03-17 2015-09-23 默克专利股份有限公司 4,6-difluorodibenzofuran derivatives
CN105153112A (en) * 2014-04-22 2015-12-16 默克专利股份有限公司 4,6-difluoro dibenzothiophene derivates
CN106045953A (en) * 2015-04-13 2016-10-26 默克专利股份有限公司 Fluorinated dibenzofuran and dibenzothiophene derivative
WO2020055463A1 (en) * 2018-09-14 2020-03-19 Apple Inc. Magnetic layout in electronic devices and accessory devices for electronic devices

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112195030A (en) * 2020-09-14 2021-01-08 北京八亿时空液晶科技股份有限公司 Liquid crystal composition containing tetrahydropyran and terphenyl and application thereof
WO2022218217A1 (en) * 2021-04-15 2022-10-20 江苏和成显示科技有限公司 Liquid crystal composition and liquid crystal display device thereof
WO2022228071A1 (en) * 2021-04-27 2022-11-03 江苏和成显示科技有限公司 Liquid crystal compound, liquid crystal composition thereof, and liquid crystal display device

Also Published As

Publication number Publication date
WO2019007821A1 (en) 2019-01-10
DE102017006284A1 (en) 2019-01-03
CN110831931B (en) 2023-06-16
TWI787298B (en) 2022-12-21
TW201906830A (en) 2019-02-16
DE112018003408A5 (en) 2020-03-12

Similar Documents

Publication Publication Date Title
CN105153112B (en) 4, 6-difluorodibenzothiophene derivatives
CN106045953B (en) Fluorinated dibenzofuran and dibenzothiophene derivatives
CN104926765B (en) 4, 6-difluorodibenzofuran derivatives
KR102565571B1 (en) Dibenzofuran derivatives and dibenzothiophene derivatives
CN110831931B (en) Thioether derivatives of dibenzothiophenes and dibenzofurans
CN109996791B (en) Monofluorinated cyclohexane
WO2016171064A1 (en) Nematic liquid crystal composition, and liquid crystal display element manufactured using same
WO2020089140A1 (en) Dibenzofuran and dibenzothiophene derivatives
JP2007039642A (en) Difluorobenzene derivative and liquid crystal composition by using the same
TWI757383B (en) Thioether compounds

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant